%0 Journal Article
%A Hoste, Levi
%A MIS-C researchers
%A Soriano-Arandes, Antoni
%A Buddingh, Emilie Pauline
%A Whittaker, Elizabeth
%A Belot, Alexandre
%A Ulloa-Gutierrez, Rolando
%A Olbrich, Peter
%A Haerynck, Filomeen
%T Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Children with a History of Multisystem Inflammatory Syndrome in Children: An International Survey.
%D 2022
%U http://hdl.handle.net/10668/22331
%X The optimal severe acute respiratory syndrome coronavirus 2 vaccine strategy for patients with a history of multisystem inflammatory syndrome in children (MIS-C) is unclear. We performed an international survey (32 countries) and found substantial variations in vaccine policies. Respondents did not report relapses of MIS-C or other severe inflammatory side effects after severe acute respiratory syndrome coronavirus 2 vaccination in 273 patients with a history of MIS-C.
%K COVID-19
%K MIS-C
%K SARS-CoV-2
%K adverse events
%K vaccination
%~